866 related articles for article (PubMed ID: 29287144)
1. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
[TBL] [Abstract][Full Text] [Related]
2. Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban.
Choi MJ; Woo MR; Choi HG; Jin SG
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012748
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban polymeric amorphous solid dispersions: Moisture-induced thermodynamic phase behavior and intermolecular interactions.
Kapourani A; Vardaka E; Katopodis K; Kachrimanis K; Barmpalexis P
Eur J Pharm Biopharm; 2019 Dec; 145():98-112. PubMed ID: 31698042
[TBL] [Abstract][Full Text] [Related]
4. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
[TBL] [Abstract][Full Text] [Related]
5. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
6. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
7. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
8. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
9. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
10. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
[TBL] [Abstract][Full Text] [Related]
11. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.
Chella N; Daravath B; Kumar D; Tadikonda RR
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):517-26. PubMed ID: 26156887
[TBL] [Abstract][Full Text] [Related]
12. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
Lim SM; Pang ZW; Tan HY; Shaikh M; Adinarayana G; Garg S
Drug Dev Ind Pharm; 2015; 41(11):1847-55. PubMed ID: 25721984
[TBL] [Abstract][Full Text] [Related]
14. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
15. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
16. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach.
Pawar J; Tayade A; Gangurde A; Moravkar K; Amin P
Eur J Pharm Sci; 2016 Jun; 88():37-49. PubMed ID: 27049050
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
18. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
19. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
20. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
